$115.01
-3.17[-2.68%]
At close: Jun 7
$115.01
0[0.00%]
After Hours: 7:53PM EDT
Albemarle Stock (NYSE:ALB), Analyst Ratings, Price Targets, Predictions
Albemarle Corp has a consensus price target of $161.75, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Scotiabank, and Deutsche Bank on May 24, 2024, May 21, 2024, and May 7, 2024. With an average price target of $144 between RBC Capital, Scotiabank, and Deutsche Bank, there's an implied 25.21% upside for Albemarle Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Scotiabank
Deutsche Bank
Mizuho
Wells Fargo
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Albemarle
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/24/2024 | Buy Now | 36.51% | RBC Capital | Arun Viswanathan | → $157 | Reiterates | Outperform → Outperform | Get Alert |
| 05/21/2024 | Buy Now | 17.38% | Scotiabank | Ben Isaacson | $150 → $135 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 05/07/2024 | Buy Now | 21.73% | Deutsche Bank | Corinne Blanchard | $125 → $140 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 30.42% | Scotiabank | Ben Isaacson | $160 → $150 | Maintains | Sector Outperform | Get Alert |
| 05/06/2024 | Buy Now | 36.51% | RBC Capital | Arun Viswanathan | $138 → $157 | Maintains | Outperform | Get Alert |
| 05/02/2024 | Buy Now | 11.29% | Mizuho | John Roberts | $112 → $128 | Maintains | Neutral | Get Alert |
| 04/11/2024 | Buy Now | 26.08% | Wells Fargo | Michael Sison | $135 → $145 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 39.12% | Berenberg | Andres Castanos Mollor | $130 → $160 | Upgrade | Hold → Buy | Get Alert |
| 04/10/2024 | Buy Now | 17.38% | Citigroup | Patrick Cunningham | $125 → $135 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | 35.64% | B of A Securities | Matthew DeYoe | $137 → $156 | Upgrade | Neutral → Buy | Get Alert |
| 03/15/2024 | Buy Now | 40.86% | Loop Capital | Christopher Kapsch | $168 → $162 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | -29.57% | Morgan Stanley | Vincent Andrews | $90 → $81 | Maintains | Underweight | Get Alert |
| 03/08/2024 | Buy Now | 26.08% | Vertical Research | Kevin McCarthy | → $145 | Downgrade | Buy → Hold | Get Alert |
| 03/07/2024 | Buy Now | -2.62% | Mizuho | John Roberts | $115 → $112 | Maintains | Neutral | Get Alert |
| 03/07/2024 | Buy Now | 38.25% | Keybanc | Aleksey Yefremov | $178 → $159 | Maintains | Overweight | Get Alert |
| 03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
| 02/27/2024 | Buy Now | -0.01% | Mizuho | John Roberts | $105 → $115 | Maintains | Neutral | Get Alert |
| 02/16/2024 | Buy Now | 17.38% | Wells Fargo | Michael Sison | $140 → $135 | Maintains | Overweight | Get Alert |
| 02/16/2024 | Buy Now | 19.99% | RBC Capital | Arun Viswanathan | $140 → $138 | Maintains | Outperform | Get Alert |
| 02/16/2024 | Buy Now | 63.46% | Oppenheimer | Colin Rusch | $191 → $188 | Maintains | Outperform | Get Alert |
| 02/16/2024 | Buy Now | 54.77% | Keybanc | Aleksey Yefremov | $199 → $178 | Maintains | Overweight | Get Alert |
| 02/15/2024 | Buy Now | 8.69% | UBS | Joshua Spector | $137 → $125 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 4.34% | Citigroup | Patrick Cunningham | $175 → $120 | Downgrade | Buy → Neutral | Get Alert |
| 01/30/2024 | Buy Now | 19.12% | UBS | Joshua Spector | $142 → $137 | Maintains | Neutral | Get Alert |
| 01/29/2024 | Buy Now | 13.03% | TD Cowen | David Deckelbaum | → $130 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/23/2024 | Buy Now | 13.03% | Mizuho | Christopher Parkinson | $152 → $130 | Maintains | Neutral | Get Alert |
| 01/17/2024 | Buy Now | 66.07% | Oppenheimer | Colin Rusch | $308 → $191 | Maintains | Outperform | Get Alert |
| 01/11/2024 | Buy Now | 23.47% | UBS | Joshua Spector | $130 → $142 | Maintains | Neutral | Get Alert |
| 01/11/2024 | Buy Now | 17.38% | Deutsche Bank | Corinne Blanchard | $155 → $135 | Downgrade | Buy → Hold | Get Alert |
| 01/09/2024 | Buy Now | 73.03% | Keybanc | Aleksey Yefremov | $200 → $199 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Albemarle (ALB)?
The latest price target for Albemarle (NYSE: ALB) was reported by RBC Capital on May 24, 2024. The analyst firm set a price target for $157.00 expecting ALB to rise to within 12 months (a possible 36.51% upside). 56 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Albemarle (ALB)?
The latest analyst rating for Albemarle (NYSE: ALB) was provided by RBC Capital, and Albemarle reiterated their outperform rating.
When was the last upgrade for Albemarle (ALB)?
The last upgrade for Albemarle Corp happened on April 11, 2024 when Berenberg raised their price target to $160. Berenberg previously had a hold for Albemarle Corp.
When was the last downgrade for Albemarle (ALB)?
The last downgrade for Albemarle Corp happened on May 21, 2024 when Scotiabank changed their price target from $150 to $135 for Albemarle Corp.
When is the next analyst rating going to be posted or updated for Albemarle (ALB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Albemarle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Albemarle was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.
Is the Analyst Rating Albemarle (ALB) correct?
While ratings are subjective and will change, the latest Albemarle (ALB) rating was a reiterated with a price target of $157.00 to $157.00. The current price Albemarle (ALB) is trading at is $115.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.